© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Angiotensin-Converting Enzyme, often known simply as ACE, plays a major role in controlling blood pressure by helping the body convert angiotensin I to the active vasoconstrictor angiotensin II. As a zinc metalloprotease, it turns up both in the lungs and in other parts of the body, ready to kick off the biochemical cascade that raises blood pressure and maintains salt and water balance. Beyond its impact on health, ACE’s unique blend of chemical and physical properties makes it important for medical and scientific research, specifically in the areas of cardiovascular diseases, hypertension, and renal function.
As a protein enzyme, ACE showcases a considerable size and complexity. Its molecular formula is represented as C27H40N10O5Zn, an arrangement that gives it a notable level of reactivity and specificity in biological contexts. ACE presents itself as a glycoprotein, which incorporates a long polypeptide chain twisted into intricate folds, giving rise to a three-dimensional structure. That sophisticated molecular scaffold binds zinc ions at its active site, a detail that is vital for its catalytic activity. As for its physicochemical state, ACE usually appears in white or off-white solid powder, occasionally in crystalline forms, depending on extraction and purification methods. Some manufacturers may offer it in lyophilized powder or flake form to improve stability and shelf life.
Once isolated and purified, ACE ranges from fine powder to small flakes, with the occasional availability in larger crystalline pearls depending on the method used to process the raw enzyme. The density of these preparations varies between about 0.3 to 0.95 g/cm³, reflecting differences in purity, hydration states, and accompanying stabilizers. In a laboratory context, the enzyme is frequently shipped as a lyophilized solid, which requires reconstitution with water or buffered solution. The resulting solution usually runs clear to slightly cloudy, remaining stable at low temperatures. Most ACE products have a specification grade that details accepted levels of purity—often exceeding 95% by electrophoresis—along with limits for endotoxins and microbial contamination.
ACE is a polypeptide, so its storage and handling come with unique precautions. It reacts with a variety of chemical inhibitors, most famously captopril and related antihypertensives, which echoes its clinical significance. Molecularly, it exhibits a high degree of structural symmetry, especially around the zinc binding site, creating a niche for targeted drug design and veterinary applications. Because ACE is not a low molecular weight compound but a large protein, inhalation or extensive skin contact is unlikely to cause acute harm, yet proper laboratory protocols prevent accidental exposure. Though not considered an environmental hazard or a volatile chemical, the enzyme is a biologically active material, calling for careful disposal under local regulations to avoid biological contamination. Spilled powder should never be swept but gently collected and disposed of as chemical-laboratory waste.
The starting materials for producing ACE come from natural sources, such as rabbit lung, or recombinant DNA techniques using bacterial or mammalian cell cultures. Each batch passes through a series of purification and lyophilization steps that remove byproducts and concentrate the active enzyme. Once prepared, the pure enzyme can be dissolved in a liter of buffer at controlled pH for use in enzymatic assays, research studies, or diagnostic kits. In solution, ACE maintains stability over a narrow temperature range—typically kept at -20°C for long-term storage—making it essential to follow storage guidelines. Its applications touch drug discovery, clinical diagnosis, and the quality control of pharmaceuticals that aim to interact with the renin-angiotensin system.
The global trade of ACE falls under HS Code 3507.90, which covers other enzymes and their preparations for industrial and laboratory applications. Importers and distributors ship ACE in powder form inside vials or sealed ampoules, each labeled with precise lot and purity information. Transport conditions require cool chains to prevent enzyme degradation, and specialty shipments might include dry ice. Laboratories often specify batch traceability, reflecting the regulatory emphasis on source transparency—an important practice since any contamination or variation can affect downstream scientific analysis.
Although ACE itself holds relatively low acute toxicity for humans, mishandling any protein of animal or recombinant origin can expose laboratory workers to allergens or carry microbial threats if not adequately purified. Careful handling with gloves, masks, and eye protection is standard practice. Given its use in the pharmaceutical and diagnostics industry, quality control ensures each product batch is free from hazardous contaminants. Disposal and spill management draw on chemical laboratory standards: gathered waste, either from slurries or unused powders, is separated for biological incineration. Regulations in different countries may require additional hazard communication on labels, even for products with low intrinsic risk, especially if ACE serves as a raw material in further biochemical synthesis.
